NSF Audits Sabinsa’s India Facilities
March 20, 2008 - News
Comments

PISCATAWAY, N.J.—Sabinsa Corp.'s manufacturing facilities in India passed a comprehensive audit by NSF International to determine adherence to GMPs (good manufacturing practices). NSF assessed the facilities’ manufacturing processes, testing and standard operating procedures (SOPs).

Todd Norton, president, Sabinsa, said, “Passing this audit just underscores our ongoing dedication to ensuring that our ingredient offerings are of exceptional quality and our continued commitment to not only meeting, but exceeding, the industry’s highest safety standards. Not only are our manufacturing facilities GMP certified, but several of our ingredient offerings, including ForsLean, Curcumin C3 Complex and Gugulipid, have also been NSF certified.”

Comments
comments powered by Disqus
Related News
News
Sabinsa Corporation's manufacturing facility in Utah is now registered to NSF International’s good
News
Sami Labs, the manufacturing arm of Sabinsa Corporation, received two Pharmexcil Awards for
News
Sabinsa will highlight its portfolio of products, ranging from curcumin to probiotics, at
News
Sami Labs, sister company of Sabinsa, has entered into a tripartite agreement with the Indian
News
Sabinsa Corp. broke ground on its new continuous extraction facility in India, which will add